Cargando…
Chemical and biological assessment of metal organic frameworks (MOFs) in pulmonary cells and in an acute in vivo model: relevance to pulmonary arterial hypertension therapy
Pulmonary arterial hypertension (PAH) is a progressive and debilitating condition. Despite promoting vasodilation, current drugs have a therapeutic window within which they are limited by systemic side effects. Nanomedicine uses nanoparticles to improve drug delivery and/or reduce side effects. We h...
Autores principales: | Mohamed, Nura A., Davies, Robert P., Lickiss, Paul D., Ahmetaj-Shala, Blerina, Reed, Daniel M., Gashaw, Hime H., Saleem, Hira, Freeman, Gemma R., George, Peter M., Wort, Stephen J., Morales-Cano, Daniel, Barreira, Bianca, Tetley, Teresa D., Chester, Adrian H., Yacoub, Magdi H., Kirkby, Nicholas S., Moreno, Laura, Mitchell, Jane A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5841901/ https://www.ncbi.nlm.nih.gov/pubmed/28447910 http://dx.doi.org/10.1177/2045893217710224 |
Ejemplares similares
-
A New NO-Releasing Nanoformulation for the Treatment of Pulmonary Arterial Hypertension
por: Mohamed, Nura A., et al.
Publicado: (2016) -
Studies on metal–organic framework (MOF) nanomedicine preparations of sildenafil for the future treatment of pulmonary arterial hypertension
por: Mohamed, Nura A., et al.
Publicado: (2021) -
Role of prostacyclin in pulmonary hypertension
por: Mitchell, Jane A., et al.
Publicado: (2014) -
Activation and Contraction of Human “Vascular” Smooth Muscle Cells Grown From Circulating Blood Progenitors
por: Ahmetaj-Shala, Blerina, et al.
Publicado: (2021) -
Ibuprofen arginate retains eNOS substrate activity and reverses endothelial dysfunction: implications for the COX-2/ADMA axis
por: Kirkby, Nicholas S., et al.
Publicado: (2016)